President Donald Trump’s executive order imposing a 10% tariff on Chinese imports is likely to drive up the cost of generic ...

Luke Walker, a director at Zentalis Pharmaceuticals, Inc. (NASDAQ:ZNTL), recently acquired additional shares of the company's common stock. According to a recent SEC filing, Walker purchased 14,200 ...

LLY is reporting earnings tomorrow and the options market predicts major moves. PFP system shows bullish positioning and ...

NEW YORK, NY / ACCESS Newswire / February 4, 2025 / If you suffered a loss on your Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) investment and ...

Nuvectis Pharma (NVCT) announced that it has commenced an underwritten public offering of its common stock. All of the shares to be sold in the ...

Though the big game has long been hallowed ground for some of the most entertaining and memorable commercials, they often don ...

The Swiss pharmaceutical company has set a high bar for any potential obesity-treatment acquisition as it scans the market for deals to fill its drug pipeline and power sales growth into the 2030s, ...

Invivyd, Inc. is a microcap biotech company focusing on antibody-based treatments for infectious diseases like COVID-19.

The modernization will enable the company to accommodate innovative technologies and expand its research capabilities. Governor Youngkin met with Haleon leadership in London in July 2024 to discuss ...

Regeneron reported Q4 2024 earnings today and declared its first-ever dividend of $0.88 per quarter. Click here to know what ...

As the nation kicks off Black History Month, a look into the industry shows there is a significant lack of Black leaders.

Regeneron Pharmaceuticals Inc.’s stock rose 4.9% Tuesday to put it on track for its biggest one-day gain in almost two years, ...